(1)
Sinaga, A. H.; Zebua, M.; Berlian, G.; Aripin, A. Pharmacoeconomic Evaluation and Clinical Outcomes of Channa As an Adjuvant to 20% Human Albumin Therapy in Patients With Chronic Kidney Disease: A Cost-Effectiveness Analysis (CEA) at Imelda Pekerja Indonesia General Hospital. JU-TI 2026, 5, 178-187.